StockWatch
·
Pharmaceuticals
Regulatory14 Aug 2026, 06:26 pm

Anlon Healthcare: Monitoring Agency Report for IPO Proceeds (June 2026)

AI Summary

Anlon Healthcare Ltd has submitted its Monitoring Agency Report for the quarter ended June 30, 2026, as required by SEBI regulations. The report, issued by CRISIL RATINGS LIMITED, covers the utilization of proceeds from its Initial Public Offer (IPO). The company reported no deviation in the utilization of funds against the objects stated in the prospectus, although a deviation was observed in the previous quarter (March 31, 2026) which was subsequently aligned with shareholder-approved changes to the objects. The net proceeds from the IPO amounted to ₹10,674.34 lakh.

Key Highlights

  • Monitoring Agency Report submitted for Q4 FY26.
  • No deviation in IPO fund utilization for the quarter.
  • Previous quarter's deviation aligned with shareholder approval.
  • Net IPO proceeds were ₹10,674.34 lakh.
  • Report issued by CRISIL RATINGS LIMITED.